Lv4
760 积分 2022-08-10 加入
Baseline, Early Changes, and Residual Albuminuria: Post-hoc Analysis of a Clinical Trial of Dapagliflozin in Chronic Kidney Disease
1个月前
已关闭
baseline, early changes, and residual albuminuria: post-hoc analysis of a clinical trial of dapagliflozin in chronic kidney disease
1个月前
已关闭
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy
1个月前
已完结
Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA Nephropathy
1个月前
已完结
Consensus statement on the management of hyperkalaemia-An Asia-Pacific perspective
2个月前
已完结
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy
2个月前
已完结
原发性IgA肾病管理和治疗中国专家共识
2个月前
已完结
[Lipid lowering: new agents and new concepts]
1年前
已完结
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)
1年前
已完结
皖公网安备34019202002308
